Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions
International Journal of Molecular Sciences · 21.06.2023 · 24 (13) · 10420
DOI: 10.3390/ijms241310420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.06.2023. Verfasst von Clara Musicco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), CNR, 70126 Bari, Italy. Hauptthemen laut MEDLINE: Mitochondria, Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondria play a key role in cancer and their involvement is not limited to the production of ATP only. Mitochondria also produce reactive oxygen species and building blocks to sustain rapid cell proliferation; thus, the deregulation of mitochondrial function is associated with cancer disease development and progression. In cancer cells, a metabolic reprogramming takes place through a different modulation of the mitochondrial metabolic pathways, including oxidative phosphorylation, fatty acid oxidation, the Krebs cycle, glutamine and heme metabolism. Alterations of mitochondrial homeostasis, in particular, of mitochondrial biogenesis, mitophagy, dynamics, redox balance, and protein homeostasis, were also observed in cancer cells. The use of drugs acting on mitochondrial destabilization may represent a promising therapeutic approach in tumors in which mitochondrial respiration is the predominant energy source. In this review, we summarize the main mitochondrial features and metabolic pathways altered in cancer cells, moreover, we present the best known drugs that, by acting on mitochondrial homeostasis and metabolic pathways, may induce mitochondrial alterations and cancer cell death. In addition, new strategies that induce mitochondrial damage, such as photodynamic, photothermal and chemodynamic therapies, and the development of nanoformulations that specifically target drugs in mitochondria are also described. Thus, mitochondria-targeted drugs may open new frontiers to a tailored and personalized cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), CNR, 70126 Bari, Italy.
- Department of Translational Biomedicine and Neuroscience, University of Bari "Aldo Moro", 70124 Bari, Italy.
- Department of Biosciences, Biotechnologies and Environment, University of Bari "Aldo Moro", 70125 Bari, Italy.
- Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", 70124 Bari, Italy.
ORCID-Profile: Clara Musicco, Vito Pesce, Antonella Cormio
Zitieren
APA
Musicco, C., Signorile, A., Pesce, V., Loguercio Polosa, P., & Cormio, A. (2023). Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions. International Journal of Molecular Sciences, 24(13), 10420. https://doi.org/10.3390/ijms241310420
Vancouver
Musicco C, Signorile A, Pesce V, Loguercio Polosa P, Cormio A. Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions. International Journal of Molecular Sciences. 2023;24(13):10420. doi:10.3390/ijms241310420
BibTeX
@article{Musicco2023,
author = {Musicco, Clara and Signorile, Anna and Pesce, Vito and Loguercio Polosa, Paola and Cormio, Antonella},
title = {Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {13},
pages = {10420},
doi = {10.3390/ijms241310420}
}
EUVIMED